Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06290310Not Yet Recruiting

Assessment of Patient-ventilator Asynchrony by Electric Impedance Tomography

Role: collaborator

NCT04174014Not ApplicableRecruiting

Optimal PEEP Titration Combining Transpulmonary Pressure Measurement and Electric Impedance Tomography

Role: collaborator

NCT04857242Not ApplicableCompleted

Electrical Impedance Tomography Measurements During Apnea Test in Patients With Suspected Brain Death

Role: collaborator

NCT04360837Not ApplicableCompleted

PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients

Role: collaborator

All 4 trials loaded